Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous-Cell Lung Cancer 1 Small Cell Lung Carcinoma 1 Retinoblastoma 1 Retinal Neoplasms 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Cancer Recurrent 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Bronchogenic 1 Bronchial Neoplasms 1 Advanced Non Small Cell Lung Cancer 1 Adenocarcinoma of Lung 1

Interventions

Paclitaxel 56 Carboplatin 56 Bevacizumab 43 Gemcitabine 20 Taxes 19 pembrolizumab 15 Immunoglobulin G 13 Disulfides 13 Topotecan 12 olaparib 11 Cisplatin 11 niraparib 9 Cyclophosphamide 9 liposomal doxorubicin 8 Specimen Handling 7 Docetaxel 6 Biopsy 6 mirvetuximab soravtansine 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Letrozole 5 Hyperthermic Intraperitoneal Chemotherapy 5 Drug Therapy 5 Cytoreduction Surgical Procedures 5 Albumin-Bound Paclitaxel 5 rucaparib 4 pazopanib 4 oregovomab 4 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fallopian Tube Neoplasms × Platinum Compounds × Clear all

NCT02489006 2024-01-17

NEO

University Health Network, Toronto

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡